141 related articles for article (PubMed ID: 10870805)
21. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants--a prospective study.
Palareti G; Legnani C; Guazzaloca G; Frascaro M; Grauso F; De Rosa F; Fortunato G; Coccheri S
Thromb Haemost; 1994 Aug; 72(2):222-6. PubMed ID: 7831656
[TBL] [Abstract][Full Text] [Related]
22. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
23. Coagulation activation and reactive fibrinolysis in patients receiving oral anticoagulation after total hip or knee replacement.
van Wersch JW; de Vries-Hanje JC; Oosterbos C
Blood Coagul Fibrinolysis; 1994 Aug; 5(4):605-8. PubMed ID: 7841318
[TBL] [Abstract][Full Text] [Related]
24. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease--a preliminary study.
Iversen LH; Okholm M; Thorlacius-Ussing O
Thromb Haemost; 1996 Oct; 76(4):523-8. PubMed ID: 8902990
[TBL] [Abstract][Full Text] [Related]
25. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823
[TBL] [Abstract][Full Text] [Related]
26. Prothrombin activation fragment 1 + 2 and thrombin-antithrombin-III complexes in plasma of patients with essential arterial hypertension.
Kłoczko J; Wojtukiewicz MZ; Galar M; Tarasów E; Jaromin J; Bielawiec M
Pol J Pharmacol; 1996; 48(2):233-5. PubMed ID: 9112658
[TBL] [Abstract][Full Text] [Related]
27. A case report of a paroxysmal nocturnal hemoglobinuria with increased coagulation activation markers while on treatment with LMWH with anti-Xa levels above the therapeutic range.
Arkel YS; Ku DH; Lake C; Lam X; Spielvogel A
Thromb Haemost; 2000 Feb; 83(2):348-9. PubMed ID: 10739398
[No Abstract] [Full Text] [Related]
28. [The changes in molecular markers for hemostatic activation after t-PA therapy in case of pulmonary embolism].
Masuoka H; Hiraoka N; Inden M; Fujioka H; Konishi T; Nakano T; Deguchi K
Kokyu To Junkan; 1992 Apr; 40(4):407-10. PubMed ID: 1315073
[TBL] [Abstract][Full Text] [Related]
29. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
30. D-dimers, thrombin-antithrombin complexes, and risk factors for thromboembolism in hospitalized patient.
Pottier P; Fouassier M; Hardouin JB; Volteau C; Planchon B
Clin Appl Thromb Hemost; 2009 Dec; 15(6):666-75. PubMed ID: 18796458
[TBL] [Abstract][Full Text] [Related]
31. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
[TBL] [Abstract][Full Text] [Related]
32. Measurement of markers of activated coagulation in antithrombin III deficient subjects.
Demers C; Ginsberg JS; Henderson P; Ofosu FA; Weitz JI; Blajchman MA
Thromb Haemost; 1992 May; 67(5):542-4. PubMed ID: 1519214
[TBL] [Abstract][Full Text] [Related]
33. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
34. Relationship between changes in F1+2 and TAT levels and blood coagulation early after prosthetic valve replacement.
Nakamura K; Toyohira H; Kariyazono H; Yamada K; Moriyama Y; Taira A
Thromb Res; 1997 Apr; 86(2):161-71. PubMed ID: 9175237
[TBL] [Abstract][Full Text] [Related]
35. The value of laboratory tests in the diagnosis of venous thromboembolism.
Sié P
Haematologica; 1995; 80(2 Suppl):57-60. PubMed ID: 7628772
[No Abstract] [Full Text] [Related]
36. Influence of conditions of blood sampling on coagulation activation markers (prothrombin fragment 1 + 2, thrombin-antithrombin complexes and D-dimers) measurements.
Leroy-Matheron C; Gouault-Heilmann M
Thromb Res; 1994 May; 74(4):399-407. PubMed ID: 8085241
[TBL] [Abstract][Full Text] [Related]
37. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
38. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
39. Determination of markers of coagulation activation and reactive fibrinolysis in patients with mechanical heart valve prosthesis at different intensities of oral anticoagulation.
van Wersch JW; van Mourik-Alderliesten CH; Coremans A
Blood Coagul Fibrinolysis; 1992 Apr; 3(2):183-6. PubMed ID: 1606289
[TBL] [Abstract][Full Text] [Related]
40. Hemostasis and fibrinolysis in patients with intermittent claudication: effects of prostaglandin E1.
Weiss C; Regele S; Velich T; Bärtsch P; Weiss T
Prostaglandins Leukot Essent Fatty Acids; 2000 Nov; 63(5):271-7. PubMed ID: 11090253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]